MESOTHELIOMA
Clinical trials for MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Trial tests Immune-Boosting drug combo for Tough-to-Treat cancer
Disease control TerminatedThis study tested whether a combination of two immunotherapy drugs, durvalumab and tremelimumab, could help control advanced malignant pleural mesothelioma. It was for people whose cancer had progressed after standard chemotherapy. The goal was to see if boosting the body's immun…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 04, 2026 02:05 UTC
-
Early cancer drug trial halted after initial safety testing
Disease control TerminatedThis early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was termina…
Matched conditions: MESOTHELIOMA
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cancer drug trial tests immune system booster for tough tumors
Disease control TerminatedThis study tested a new drug called TAK-500, designed to activate the immune system to fight cancer. It was given alone or combined with an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that had stopped responding to standard treatments. The mai…
Matched conditions: MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC